Showing 4391-4400 of 19393 results for "".
Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
https://reachmd.com/programs/clinicians-roundtable/saliva-as-a-window-into-cystic-fibrosis-metabolic-biomarkers-and-clinical-potential/35665/In a 2025 study investigating salivary metabolites as potential biomarkers in cystic fibrosis, researchers identified distinct metabolic patterns linked with key complications as well as correlations with lung function. In this AudioAbstract, Ryan Quigley discusses how a simple saliva sample could pDetecting Sjögren’s Disease Early: Why Education and Awareness Matters
https://reachmd.com/programs/living-rheum/detecting-sjogrens-disease-early-why-education-and-awareness-matters/36348/Despite progress in reducing diagnostic delays, systemic barriers and limited provider recognition still contribute to missed or late diagnoses of Sjögren’s disease. Because of this, continued outreach and balanced, accessible education remain essential to improving early identification and care. LeRethinking Chronic Pain: A Biopsychosocial Approach to Management
https://reachmd.com/programs/living-rheum/rethinking-chronic-pain-a-biopsychosocial-approach-to-management/32818/Chronic pain is now recognized as a distinct disease that requires more than just a symptom-based approach. Lifestyle factors and psychological health are also important considerations for care, which is why a biopsychosocial approach can be key to better outcomes. Hear Dr. Martin Cheatle discuss thDifferentiating and Diagnosing Sjögren’s-Related Dry Eye
https://reachmd.com/programs/living-rheum/differentiating-and-diagnosing-sjogrens-related-dry-eye/36338/Recognizing when dry eye symptoms are related to Sjögren’s disease is an important step in the diagnostic process for this rare autoimmune condition. Tune in to hear Dr. Michelle Hessen, an Assistant Professor of Ophthalmology at the Wilmer Eye Institute and a member of the Ocular Surface Disease anAssessing Competitive Bidding’s Effect on COPD Oxygen Utilization
https://reachmd.com/programs/frontlines-copd/assessing-competitive-biddings-effect-on-copd-oxygen-utilization/35543/Due to concerns about reduced access and care quality following the implementation of Medicare’s Competitive Bidding Program, a recent study examined the program’s real-world impacts on supplemental oxygen use in patients with COPD. While the findings showed no significant effect on clinical outcomeEarly-Stage Prostate Cancer Treatment: Examining Long-Term Complications
https://reachmd.com/programs/frontlines-prostate-cancer/early-stage-prostate-cancer-treatment-examining-long-term-complications/32214/Patients may experience complications from early-stage prostate cancer therapy. Hear clinical data on these risks and their impact on treatment decisions.Uncovering Disparities in Teleneurology Utilization Post-Pandemic
https://reachmd.com/programs/frontlines-multiple-sclerosis/uncovering-disparities-in-teleneurology-utilization-post-pandemic/32663/Teleneurology has the potential to expand access to care, but could it also inadvertently widen disparities? That’s what a recent study sought to answer.Patient Selection and Assessment
https://reachmd.com/programs/modern-aesthetics/Patient-Selection-Assessment/32707/Aesthetic treatment outcomes are dependent on a number of factors, including the products that are used and the clinician’s skill level. Perhaps just as important—or even more so—is patient selection. Modern Aesthetics® convened an expert roundtable to discuss physical and mental considerations, howManaging High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
https://reachmd.com/programs/project-oncology/managing-high-risk-myeloma-from-cytogenetic-abnormalities-to-therapeutic-approaches/26583/Tune in to gain insights into high-risk multiple myeloma, like the genetic factors that play a role in its development as well as treatment options.Biosimilars for the Treatment of Psoriasis
https://reachmd.com/programs/dermconsult/biosimilars-for-the-treatment-of-psoriasis/15986/Psoriasis is an autoimmune condition that causes the immune system to attack healthy skin cells, which leads to buildup of dead skin cells on the surface of the skin.